Cerity Partners LLC Has $1.89 Million Stock Position in Azenta, Inc. (NASDAQ:AZTA)

Cerity Partners LLC raised its holdings in Azenta, Inc. (NASDAQ:AZTA) by 21.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 39,031 shares of the company’s stock after buying an additional 6,840 shares during the quarter. Cerity Partners LLC owned 0.08% of Azenta worth $1,891,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Hantz Financial Services Inc. acquired a new position in shares of Azenta during the 2nd quarter valued at $30,000. Farther Finance Advisors LLC raised its holdings in shares of Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock valued at $74,000 after purchasing an additional 256 shares during the period. Benjamin F. Edwards & Company Inc. boosted its position in shares of Azenta by 150.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock worth $84,000 after purchasing an additional 955 shares in the last quarter. Net Worth Advisory Group acquired a new stake in shares of Azenta in the 3rd quarter valued at about $205,000. Finally, Aigen Investment Management LP bought a new stake in Azenta in the 3rd quarter valued at about $214,000. 99.08% of the stock is currently owned by institutional investors.

Insider Activity at Azenta

In related news, Director William L. Cornog purchased 12,500 shares of the firm’s stock in a transaction dated Monday, November 18th. The stock was bought at an average price of $39.60 per share, for a total transaction of $495,000.00. Following the purchase, the director now directly owns 14,755 shares in the company, valued at approximately $584,298. This trade represents a 554.32 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Herman Cueto sold 1,595 shares of the company’s stock in a transaction that occurred on Thursday, October 17th. The shares were sold at an average price of $43.68, for a total value of $69,669.60. Following the completion of the transaction, the chief financial officer now owns 24,604 shares in the company, valued at approximately $1,074,702.72. The trade was a 6.09 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 3,018 shares of company stock valued at $126,689. 1.77% of the stock is owned by insiders.

Azenta Trading Up 2.2 %

NASDAQ AZTA opened at $47.21 on Tuesday. The business has a fifty day simple moving average of $44.95 and a 200 day simple moving average of $49.87. Azenta, Inc. has a 12 month low of $38.82 and a 12 month high of $69.16. The firm has a market capitalization of $2.31 billion, a P/E ratio of -15.69 and a beta of 1.48.

Azenta (NASDAQ:AZTA) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.10 by $0.08. The company had revenue of $170.00 million for the quarter, compared to analyst estimates of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The firm’s revenue was down 1.2% on a year-over-year basis. During the same period last year, the firm earned $0.13 earnings per share. As a group, sell-side analysts predict that Azenta, Inc. will post 0.4 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AZTA has been the subject of several recent research reports. Evercore ISI decreased their price objective on Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a report on Tuesday, October 1st. Needham & Company LLC decreased their price target on shares of Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $63.60.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.